Lung Cancer News

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Healio spoke with Melina Elpi Marmarelis, MD, about data from the INSIGHT 2 trial presented at this year’s International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Melina Elpi Marmarelis, MD, discussed research on the use of osimertinib versus durvalumab following chemoradiation in patients with stage III EGFR-mutated NSCLC.

Osimertinib plus chemotherapy may benefit some lung cancer subsets compared with osimertinib alone, according to recent research from the FLAURA2 trial.

Healio spoke with Melina Elpi Marmarelis, MD, about key takeaways from the MARS 2 trial presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

Lung cancer incidence remained higher among U.S. women aged younger than 50 years compared with men, according to a research letter published in JAMA Oncology.

The FDA approved encorafenib plus binimetinib for treatment of certain patients with non-small cell lung cancer.

Pembrolizumab as neoadjuvant and adjuvant therapy significantly extended OS among adults with resectable stage II, IIIA or IIIB non-small cell lung cancer, according to the agent’s manufacturer.

Information AI-powered chatbots provided related to search queries on the most common cancer types generally produced accurate information with poor actionability, study results published in JAMA Oncology showed.

HONOLULU — A model that incorporates demographic and smoking history data has identified regions populated with individuals eligible for lung cancer screening, according to study results presented at the CHEST Annual Meeting.